GENinCode Full Year 2023 Earnings: Revenues Disappoint

GENinCode (LON:GENI) Full Year 2023 Results

Key Financial Results

• Revenue: UK£2.16m (up 51% from FY 2022).
• Net loss: UK£7.02m (loss widened by 26% from FY 2022).
• UK£0.07 loss per share (further deteriorated from UK£0.058 loss in FY 2022).

All figures shown in the chart above are for the trailing 12 month (TTM) period

GENinCode Revenues Disappoint

Revenue missed analyst estimates by 1.3%. Earnings per share (EPS) was mostly in line with analyst estimates.

The company's shares are down 18% from a week ago.

Risk Analysis

You should learn about the 7 warning signs we've spotted with GENinCode (including 4 which can't be ignored).

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.